RAC 0.59% $1.71 race oncology ltd

I agree, all the other risks are just systematic risks that...

  1. 2,795 Posts.
    lightbulb Created with Sketch. 2857
    I agree, all the other risks are just systematic risks that equally apply to all biotechs. Risk needs to be assessed ‘relative’ to other companies. Next hurdle or risk is does CPACS translate to the clinic. If you are invested you are of the opinion it will, unless you are looking for an AML (only) outcome.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.